Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

277 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Predictive and Dynamic Signature for Antiangiogenics in Combination with a PD1 Inhibitor in Soft-Tissue Sarcoma: Correlative Studies Linked to the IMMUNOSARC Trial.
Moura DS, Lopez-Marti JM, Benesova I, de Andrea C, di Lernia D, Lacerenza S, Mondaza-Hernandez JL, Martin-Ruiz M, Ramirez-Calvo M, Grignani G, Martinez-Trufero J, Redondo A, Valverde C, Stacchiotti S, Lopez-Pousa A, Lopez-Guerrero JA, Gutierrez A, Encinas-Tobajas V, Hindi N, Sangiolo D, Lopez-Martin JA, Strizova ZO, Martin-Broto J. Moura DS, et al. Among authors: stacchiotti s. Clin Cancer Res. 2024 Nov 15;30(22):5192-5206. doi: 10.1158/1078-0432.CCR-24-1782. Clin Cancer Res. 2024. PMID: 39283727
Response to sunitinib malate in advanced alveolar soft part sarcoma.
Stacchiotti S, Tamborini E, Marrari A, Brich S, Rota SA, Orsenigo M, Crippa F, Morosi C, Gronchi A, Pierotti MA, Casali PG, Pilotti S. Stacchiotti S, et al. Clin Cancer Res. 2009 Feb 1;15(3):1096-104. doi: 10.1158/1078-0432.CCR-08-2050. Clin Cancer Res. 2009. PMID: 19188185 Free article.
A phase 2 trial of imatinib mesylate in patients with recurrent nonresectable chondrosarcomas expressing platelet-derived growth factor receptor-α or -β: An Italian Sarcoma Group study.
Grignani G, Palmerini E, Stacchiotti S, Boglione A, Ferraresi V, Frustaci S, Comandone A, Casali PG, Ferrari S, Aglietta M. Grignani G, et al. Among authors: stacchiotti s. Cancer. 2011 Feb 15;117(4):826-31. doi: 10.1002/cncr.25632. Epub 2010 Oct 5. Cancer. 2011. PMID: 20925044 Free article. Clinical Trial.
Short, full-dose adjuvant chemotherapy in high-risk adult soft tissue sarcomas: a randomized clinical trial from the Italian Sarcoma Group and the Spanish Sarcoma Group.
Gronchi A, Frustaci S, Mercuri M, Martin J, Lopez-Pousa A, Verderio P, Mariani L, Valagussa P, Miceli R, Stacchiotti S, Dei Tos AP, De Paoli A, Longhi A, Poveda A, Quagliuolo V, Comandone A, Casali PG, Picci P. Gronchi A, et al. Among authors: stacchiotti s. J Clin Oncol. 2012 Mar 10;30(8):850-6. doi: 10.1200/JCO.2011.37.7218. Epub 2012 Feb 6. J Clin Oncol. 2012. PMID: 22312103 Clinical Trial.
Phase II study of imatinib in advanced chordoma.
Stacchiotti S, Longhi A, Ferraresi V, Grignani G, Comandone A, Stupp R, Bertuzzi A, Tamborini E, Pilotti S, Messina A, Spreafico C, Gronchi A, Amore P, Vinaccia V, Casali PG. Stacchiotti S, et al. J Clin Oncol. 2012 Mar 20;30(9):914-20. doi: 10.1200/JCO.2011.35.3656. Epub 2012 Feb 13. J Clin Oncol. 2012. PMID: 22331945 Clinical Trial.
Tumor response assessment by modified Choi criteria in localized high-risk soft tissue sarcoma treated with chemotherapy.
Stacchiotti S, Verderio P, Messina A, Morosi C, Collini P, Llombart-Bosch A, Martin J, Comandone A, Cruz J, Ferraro A, Grignani G, Pizzamiglio S, Quagliuolo V, Picci P, Frustaci S, Dei Tos AP, Casali PG, Gronchi A. Stacchiotti S, et al. Cancer. 2012 Dec 1;118(23):5857-66. doi: 10.1002/cncr.27624. Epub 2012 May 17. Cancer. 2012. PMID: 22605504 Free article.
MRP1 overexpression determines poor prognosis in prospectively treated patients with localized high-risk soft tissue sarcoma of limbs and trunk wall: an ISG/GEIS study.
Martin-Broto J, Gutierrez AM, Ramos RF, Lopez-Guerrero JA, Ferrari S, Stacchiotti S, Picci P, Calabuig S, Collini P, Gambarotti M, Bague S, Dei Tos AP, Palassini E, Luna P, Cruz J, Cubedo R, Martinez-Trufero J, Poveda A, Casali PG, Fernandez-Serra A, Lopez-Pousa A, Gronchi A. Martin-Broto J, et al. Among authors: stacchiotti s. Mol Cancer Ther. 2014 Jan;13(1):249-59. doi: 10.1158/1535-7163.MCT-13-0406. Epub 2013 Oct 21. Mol Cancer Ther. 2014. PMID: 24145283
Response of conventional chondrosarcoma to gemcitabine alone: a case report.
Provenzano S, Hindi N, Morosi C, Ghilardi M, Collini P, Casali PG, Stacchiotti S. Provenzano S, et al. Among authors: stacchiotti s. Clin Sarcoma Res. 2015 Mar 15;5:9. doi: 10.1186/s13569-015-0025-z. eCollection 2015. Clin Sarcoma Res. 2015. PMID: 25793102 Free PMC article.
Imatinib in advanced chordoma: A retrospective case series analysis.
Hindi N, Casali PG, Morosi C, Messina A, Palassini E, Pilotti S, Tamborini E, Radaelli S, Gronchi A, Stacchiotti S. Hindi N, et al. Among authors: stacchiotti s. Eur J Cancer. 2015 Nov;51(17):2609-14. doi: 10.1016/j.ejca.2015.07.038. Epub 2015 Aug 14. Eur J Cancer. 2015. PMID: 26283036
277 results